#news #biotech Bavarian Nordic delays phase 3 cancer vaccine data again, pushing back Bristol-Myers opt-in decision date

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Bavarian Nordic delays phase 3 cancer vaccine data again, pushing back Bristol-Myers opt-in decision date .Bavarian Nordic has again delayed the release of data from a phase 3 trial of Prostvac. Top-line data on the Bristol-Myers Squibb-partnered prostate cancer vaccine are now due to drop in the fourth quarter, with the delayed third interim analysis penciled in for September.

from FierceBiotech: Biotech http://ift.tt/2sGogh1